Investigational Drug Information for Soticlestat
What is the drug development status for Soticlestat?
Soticlestat is an investigational drug.
There have been 13 clinical trials for Soticlestat.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 25th 2024.
The most common disease conditions in clinical trials are Syndrome, Epilepsies, Myoclonic, and Lennox Gastaut Syndrome. The leading clinical trial sponsors are Takeda, Ovid Therapeutics Inc., and Millennium Pharmaceuticals, Inc.
There are fifteen US patents protecting this investigational drug and fifty international patents.
Summary for Soticlestat
| US Patents | 15 |
| International Patents | 50 |
| US Patent Applications | 43 |
| WIPO Patent Applications | 18 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 2 (2024-04-25) |
| Vendors | 34 |
Recent Clinical Trials for Soticlestat
| Title | Sponsor | Phase |
|---|---|---|
| A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine | Takeda | PHASE3 |
| A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience | Takeda | Phase 1 |
| A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval | Takeda | Phase 1 |
Clinical Trial Summary for Soticlestat
Top disease conditions for Soticlestat
Top clinical trial sponsors for Soticlestat
US Patents for Soticlestat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Soticlestat | ⤷ Start Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Start Trial |
| Soticlestat | ⤷ Start Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Start Trial |
| Soticlestat | ⤷ Start Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Start Trial |
| Soticlestat | ⤷ Start Trial | Method for producing heterocyclic compound | Takeda Pharmaceutical Co Ltd | ⤷ Start Trial |
| Soticlestat | ⤷ Start Trial | 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases | TAKEDA PHARMACEUTICAL COMPANY LIMITED (Osaka, JP) | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Soticlestat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Soticlestat | Argentina | AR088226 | 2031-10-07 | ⤷ Start Trial |
| Soticlestat | Australia | AU2012321815 | 2031-10-07 | ⤷ Start Trial |
| Soticlestat | Brazil | BR112014007257 | 2031-10-07 | ⤷ Start Trial |
| Soticlestat | Canada | CA2851087 | 2031-10-07 | ⤷ Start Trial |
| Soticlestat | Chile | CL2014000806 | 2031-10-07 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
